Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity.
- DOI
- 10.1016/j.molmet.2026.102468
- Published
- 2026-10
- Container
- Molecular Metabolism
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.molmet.2026.102468,
title = {Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity.},
author = {Kristoffer Niss and Sofia Lundh and Rucha Patel and Johannes Josef Fels and Albrecht Gruhler and Suzi Høgh Madsen and Fabrice Chimienti and Sarah Bau and Dennis Åsberg and Lennart Lykke and Nick Cox and Birgitte S. Wulff and Nikolaj Kulahin Roed and Chien Li and Berit Ø. Christoffersen},
year = {2026},
journal = {Molecular Metabolism},
doi = {10.1016/j.molmet.2026.102468},
url = {https://doi.org/10.1016/j.molmet.2026.102468}
}RIS
TY - JOUR TI - Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity. AU - Kristoffer Niss AU - Sofia Lundh AU - Rucha Patel AU - Johannes Josef Fels AU - Albrecht Gruhler AU - Suzi Høgh Madsen AU - Fabrice Chimienti AU - Sarah Bau AU - Dennis Åsberg AU - Lennart Lykke AU - Nick Cox AU - Birgitte S. Wulff AU - Nikolaj Kulahin Roed AU - Chien Li AU - Berit Ø. Christoffersen PY - 2026 JO - Molecular Metabolism DO - 10.1016/j.molmet.2026.102468 UR - https://doi.org/10.1016/j.molmet.2026.102468 ER -
APA
Niss, K., Lundh, S., Patel, R., Fels, J. J., Gruhler, A., Madsen, S. H., Chimienti, F., Bau, S., Åsberg, D., Lykke, L., Cox, N., Wulff, B. S., Roed, N. K., Li, C., & Christoffersen, B. Ø. (2026). Differentiated obesity treatment: Pharmacological CRF2 agonism drives fat loss, skeletal muscle hypertrophy and improved glucose metabolism in preclinical obesity.. Molecular Metabolism. https://doi.org/10.1016/j.molmet.2026.102468
Source records
- crossref · retrieved 2026-11-10T16:48:22.798Z